سعر توريار Toriar‏ 10مجم 20 اقراص 2026

Ritodrine 10 mg film-coated tablets, pack of 20, by Unipharma (Egypt); beta-2 agonist tocolytic.

• Serious: rhabdomyolysis, pancytopenia, decreased serum potassium, hyperglycaemia/diabetic ketoacidosis, neonatal intestinal obstruction.General active-ingredient information · JAPIC (Japan Pharmaceutical Information Center) / PMDA
• Other: palpitations/tachycardia (>=5%), facial flushing, dizziness, nausea, raised AST/ALT, thrombocytopenia, rash; fetal/neonatal tachycardia and neonatal hypoglycaemia reported.General active-ingredient information · JAPIC (Japan Pharmaceutical Information Center) / PMDA

• Severe uterine bleeding, eclampsia, premature rupture of membranes with intrauterine infection, placental abruption, intrauterine fetal death or other situations where continuing pregnancy is dangerous.General active-ingredient information · JAPIC (Japan Pharmaceutical Information Center) / PMDA
• Severe hyperthyroidism, severe hypertension, severe heart disease, severe diabetes, severe pulmonary hypertension.General active-ingredient information · JAPIC (Japan Pharmaceutical Information Center) / PMDA
• Pregnancy of less than 16 weeks; history of serious hypersensitivity to the components.General active-ingredient information · JAPIC (Japan Pharmaceutical Information Center) / PMDA

• Rapid rise in blood glucose, worsening diabetes and diabetic ketoacidosis may occur; monitor for thirst, polyuria, blood/urine glucose and ketones.General active-ingredient information · JAPIC (Japan Pharmaceutical Information Center) / PMDA
• Adverse reactions become more likely at daily doses above 30 mg.General active-ingredient information · JAPIC (Japan Pharmaceutical Information Center) / PMDA
• Use with caution in hyperthyroidism, hypertension, heart disease, diabetes or its risk factors, pulmonary hypertension and muscle diseases such as myotonic dystrophy (rhabdomyolysis risk).General active-ingredient information · JAPIC (Japan Pharmaceutical Information Center) / PMDA

• Beta-agonistsAdditive enhancement of effects.JAPIC (Japan Pharmaceutical Information Center) / PMDA
• Beta-blockersEffects may be reduced by competitive antagonism at beta receptors.JAPIC (Japan Pharmaceutical Information Center) / PMDA
• Potassium-depleting diureticsRisk of excessive decrease in serum potassium.JAPIC (Japan Pharmaceutical Information Center) / PMDA

• Contraindicated before 16 weeks of gestation (safety and efficacy not established).General active-ingredient information · JAPIC (Japan Pharmaceutical Information Center) / PMDA
• If given just before delivery, consider the benefit of breastfeeding when deciding on breastfeeding immediately after birth; excretion into milk reported in rats.General active-ingredient information · JAPIC (Japan Pharmaceutical Information Center) / PMDA

• Ritodrine: Selective beta-receptor stimulation increases cAMP and lowers intracellular Ca2+, relaxing uterine smooth muscle (Japanese label).